Skip to main content

JANE STREET GROUP, LLC

Position in ALXO — Alx Oncology Holdings Inc

CIK 1595888 NEW YORK, NY

Position in ALXO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$190,677
-$19,458 QoQ
Shares Held
95,101
-48.9% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 68 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALXO Over Time

Shares Held

Position Value (USD)

Derivatives in ALXO

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$23,165
PutShares
20,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names. ALXO ranks #222 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALXO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $190,677 95,101
2025-12-31 $23,165 20,500
2025-12-31 $210,135 185,961
2025-09-30 $330,160 180,416
2025-06-30 $84,354 203,266
2024-12-31 $34,157 20,454
2024-09-30 $50,810 27,918
2024-06-30 $470,942 78,100
2024-03-31 $660,024 59,195
2023-12-31 $649,173 43,598
2023-03-31 $100,673 22,273
2022-09-30 $143,865 15,033
2021-09-30 $694,284 9,400